Psoriasis treatment with quinazoline compounds
US6004967A · kind A · utility
25Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 1997 |
| Grant date | Dec 21, 1999 |
| Priority date | — |
| Expiry date | Sep 11, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/517
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to methods and compositions for treating hyperproliferative skin disorders utilizing a quinazoline derivative as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.